Ongoing research in the field relies on dependable assay tools, such as antibodies that produce high-quality, verifiable data in routine immuno-oncology applications. Characterize immune-cell and tumor markers, T-cell markers and immune checkpoints using validated antibodies for tumor microenvironment research.
Quickly detect multiple antigens in a single tissue section to gain a clear understanding of the tumor microenvironment without compromising samples with Bethyl PathPlex® panels. Each antibody has been validated for immunohistochemistry (IHC) and utilized in a multiplex format by our scientists via proprietary processes to ensure the highest quality.
Trial sizes are ideal for comparisons between suppliers or various application testings and cost effective at $99 US. Over 6,000 trial-sized antibodies are available to more than 3,300 protein targets, and new releases are continuing to be added every month.
Bethyl's purpose is to improve lives by supporting scientific discovery. This drives our complete dedication to the highest standards of product and service quality.